Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling
- PMID: 11719464
Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling
Abstract
Transforming growth factor (TGF)-beta is growth inhibitory for normal epithelial cells and melanocytes but can stimulate mesenchymal cells. Resistance to its inhibitory effects is characteristic of human melanoma, the growth of which may instead be promoted by TGF-beta, because its production is increased with melanoma progression. Whether TGF-beta has an autocrine function for melanoma cells or is important for paracrine stimulation of the tumor stroma is not known. In this study, TGF-beta1 was expressed in melanoma cells via adenoviral gene transfer, and tumor growth was analyzed in vitro, in human skin grafts, and in mixtures with fibroblasts that were injected s.c. into immunodeficient mice. The TGF-beta1 produced by the melanoma cells activated the fibroblasts to produce matrix within and around the tumor mass, whereas control tumors showed less stroma and more cell death. High expression of collagen, fibronectin, tenascin, and alpha2 integrin was detected in the TGF-beta1-expressing tumors by immunohistochemistry. Number and size of lung metastases were significantly increased. cDNA expression array analysis of TGF-beta1-transduced fibroblasts embedded in type I collagen and of TGF-beta1-transduced melanoma cells demonstrated induction of types XV, XVIII, and VI collagens, tenascin, plasminogen activator inhibitor-I, vascular endothelial growth factor, cysteine-rich fibroblast growth factor receptor-1, and platelet-derived growth factor receptor-beta, which could be linked to promotion of growth and survival in melanoma. These data suggest that remodeling of the neighboring stroma, which provides a supporting scaffolding and a positive feedback stimulation of tumor growth, is an important function of TGF-beta1 in melanoma.
Similar articles
-
Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.Hum Pathol. 2002 Dec;33(12):1193-9. doi: 10.1053/hupa.2002.130109. Hum Pathol. 2002. PMID: 12514788
-
Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.Mol Carcinog. 2004 Jun;40(2):116-21. doi: 10.1002/mc.20024. Mol Carcinog. 2004. PMID: 15170816
-
Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.Clin Cancer Res. 2002 Sep;8(9):2912-23. Clin Cancer Res. 2002. PMID: 12231536
-
Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.Cells Tissues Organs. 2007;185(1-3):116-22. doi: 10.1159/000101312. Cells Tissues Organs. 2007. PMID: 17587817 Review.
-
Cytokines and human fibrosis.Eur Cytokine Netw. 1990 Oct-Nov;1(4):215-9. Eur Cytokine Netw. 1990. PMID: 1966552 Review.
Cited by
-
Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.Exp Cell Res. 2006 May 1;312(8):1401-17. doi: 10.1016/j.yexcr.2006.01.003. Epub 2006 Feb 17. Exp Cell Res. 2006. PMID: 16487513 Free PMC article.
-
VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.EMBO J. 2004 Jul 21;23(14):2800-10. doi: 10.1038/sj.emboj.7600289. Epub 2004 Jul 1. EMBO J. 2004. PMID: 15229650 Free PMC article.
-
Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition.Pigment Cell Melanoma Res. 2011 Jun;24(3):512-24. doi: 10.1111/j.1755-148X.2011.00858.x. Epub 2011 Apr 28. Pigment Cell Melanoma Res. 2011. PMID: 21477078 Free PMC article.
-
Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.J Clin Invest. 2009 Aug;119(8):2399-411. doi: 10.1172/JCI37155. Epub 2009 Jul 20. J Clin Invest. 2009. PMID: 19620789 Free PMC article.
-
Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma.J Cell Physiol. 2013 Apr;228(4):773-80. doi: 10.1002/jcp.24225. J Cell Physiol. 2013. PMID: 23001823 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous